RAPT Therapeutics, Inc. — Director's Dealing 2021

Jan 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-01-05

Reporting Person: Brockstedt Dirk G. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-05	Common Stock	S	821	$19.763	Disposed	18735	Direct
2021-01-06	Common Stock	S	1179	$19.68	Disposed	17556	Direct

Footnotes

F1: These shares were sold solely to pay taxes due upon vesting of the Restricted Stock Units granted on January 30, 2020 for 8,000 shares.

F2: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.